The association between baseline physical and mental health and the risk of postacute sequelae of COVID-19 infection.

Publication date: Jul 08, 2025

Post-acute sequelae of COVID-19 infection (PASC) is a widely reported phenomenon wherein symptoms of COVID-19 infection persist for four weeks or more beyond acute infection. Risk factors at baseline (prior to infection) for the development of PASC are not well understood. This study aimed to identify baseline demographic, physical and mental health characteristics associated with the development of PASC. We identified 351 participants who reported contracting COVID-19 and 145 that experienced PASC symptoms. Baseline physical health, mental health, and demographic data were collected for all participants. Risk factors for the development of PASC were identified using multivariable logistic regression. PASC was associated with lower income, Hispanic ethnicity, younger age, and respiratory conditions (asthma or COPD). Worse self-reported mental health status, a diagnosis of depression, and a higher patient health questionnaire-2 (PHQ-2) score were also associated with PASC. We then used latent class analysis and identified two subtypes of PASC, one with fewer PASC symptoms (n = 112) and another with many PASC symptoms (n = 33). Risk factors for membership in each class were different, but a past diagnosis of depression predicted membership in both classes compared to those without PASC. A diagnosis of depression was more strongly associated with the “many symptoms” class compared to the “few symptoms” class. We find that several mental health and demographic risk factors are linked to PASC. More research is necessary to understand both the two subtypes of PASC identified in our analysis, and the underlying relationship between COVID-19 infection and PASC.

Open Access PDF

Concepts Keywords
Asthma Adult
Covid Aged
Health COVID-19
Hispanic Depression
Postacute Female
Health Status
Humans
Long COVID
Male
Mental Health
Mental health
Middle Aged
PASC
Post-Acute COVID-19 Syndrome
Risk Factors
SARS-CoV-2

Semantics

Type Source Name
disease MESH sequelae
disease MESH COVID-19
disease MESH infection
disease MESH Post-acute sequelae of COVID-19
disease IDO acute infection
disease MESH asthma
pathway KEGG Asthma
disease MESH COPD
disease MESH health status
disease MESH depression
drug DRUGBANK Factor IX Complex (Human)
disease MESH brain fog
disease MESH obesity
drug DRUGBANK Coenzyme M
disease MESH anxiety
disease IDO history
disease MESH mental illness
disease MESH chronic conditions
disease MESH heart attack
disease MESH stroke
disease MESH high blood pressure
disease MESH cancer
disease MESH kidney disease
disease MESH arthritis
disease MESH hepatitis
disease MESH heart disease
drug DRUGBANK Ethanol
drug DRUGBANK Medical Cannabis
disease MESH Joint Pain

Original Article

(Visited 1 times, 1 visits today)